Floatz logo

L-Bupivacaine

Ultrasound Therapy; Complications

Hospital Medina del CampoSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

13 Active assets in the Ultrasound Therapy; Complications cohort.

Asset / SponsorPhaseRating
Velpatasvir
Alexandria University
Phase 4BB
AUTOLOGOUS CONDITIONED PLASMA
Star Spine and Sport
Phase 4BB
Sofosbuvir
Alexandria University
Phase 4BB
NEPENTHE
Tiva Group
Phase 4BB
NADROPARIN
Rijnstate Hospital
Phase 4BB

View all 37 →

Same molecule, other indications

L-Bupivacaine is also rated in:

Lymph Node DissectionDormant
BB
Indicative ·
68 / 100
View asset →
Surgical Wound InfiltrationDormant
BB
Indicative ·
68 / 100
View asset →
breast cancerDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →